JP2007527417A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007527417A5 JP2007527417A5 JP2006541459A JP2006541459A JP2007527417A5 JP 2007527417 A5 JP2007527417 A5 JP 2007527417A5 JP 2006541459 A JP2006541459 A JP 2006541459A JP 2006541459 A JP2006541459 A JP 2006541459A JP 2007527417 A5 JP2007527417 A5 JP 2007527417A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- alkenyl
- pharmaceutical formulation
- administered
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 *C(*)(*)C(OC(CC1(*)*)CC(*)(*)N1O)=O Chemical compound *C(*)(*)C(OC(CC1(*)*)CC(*)(*)N1O)=O 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52380303P | 2003-11-20 | 2003-11-20 | |
| PCT/US2004/039716 WO2005055926A2 (en) | 2003-11-20 | 2004-11-22 | Amelioration of cataracts, macular degeneration and other ophthalmic diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007527417A JP2007527417A (ja) | 2007-09-27 |
| JP2007527417A5 true JP2007527417A5 (https=) | 2008-01-17 |
Family
ID=34676585
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006541459A Pending JP2007527417A (ja) | 2003-11-20 | 2004-11-22 | 白内障、黄斑変性および他の眼疾患の改善 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1689354A4 (https=) |
| JP (1) | JP2007527417A (https=) |
| KR (1) | KR20070040326A (https=) |
| CN (1) | CN101102770A (https=) |
| AU (1) | AU2004296738A1 (https=) |
| CA (1) | CA2546053A1 (https=) |
| IL (1) | IL175498A0 (https=) |
| WO (1) | WO2005055926A2 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7589107B2 (en) | 2003-05-19 | 2009-09-15 | Othera Holding, Inc. | Amelioration of vitrectomy-induced cataracts |
| US20080312283A1 (en) * | 2005-05-26 | 2008-12-18 | Othera Pharmaceuticals, Inc. | Use of Hydroxylamine Derivates for Inhibiting Vitrectomy-Induced Cataracts |
| AU2007221271A1 (en) * | 2006-02-22 | 2007-09-07 | Othera Holding, Inc. | Hydroxylamines and derivatives for the inhibition of complement activation |
| WO2008101195A2 (en) * | 2007-02-16 | 2008-08-21 | Othera Holding, Inc. | Drug resistance reversal in neoplastic disease |
| EP2620429A1 (en) * | 2007-02-22 | 2013-07-31 | Colby Pharmaceutical Company | Hydroxylamine compounds and methods of their use |
| CA2707158A1 (en) * | 2007-11-28 | 2009-06-04 | Revision Therapeutics, Inc. | Modulators of ocular oxidative stress |
| EP2080513A1 (en) * | 2008-01-16 | 2009-07-22 | Schraermeyer, Ulrich, Prof. Dr. rer. nat | Tetrahydropyridoethers for treatment of AMD |
| CN102988331B (zh) * | 2012-05-31 | 2015-02-04 | 管孝君 | 2-巯基-3-丁醇用于制备抗晶状体混浊产品的用途 |
| CA2946422C (en) * | 2014-04-30 | 2019-03-05 | The Johns Hopkins University | Dendrimer compositions and their use in treatment of diseases of the eye |
| CA2957721C (en) | 2014-08-13 | 2021-04-13 | The Johns Hopkins University | Selective dendrimer delivery to brain tumors |
| US20170246176A1 (en) * | 2014-10-31 | 2017-08-31 | Keio University | Phacosclerosis inhibitor |
| AU2018258654B2 (en) | 2017-04-27 | 2022-01-06 | The Johns Hopkins University | Dendrimer compositions for use in angiography |
| US20200038355A1 (en) * | 2017-04-28 | 2020-02-06 | Case Western Reserve University | Antioxidants for use in ophthalmic surgery |
| EP3707193A1 (en) | 2017-11-10 | 2020-09-16 | The Johns Hopkins University | Dendrimer delivery system and methods of use thereof |
| JP7759322B2 (ja) | 2019-12-04 | 2025-10-23 | アシュバッタ セラピューティクス， インコーポレイテッド | 眼に薬物送達するためのデンドリマー組成物および方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5352442A (en) * | 1985-07-18 | 1994-10-04 | Proctor Peter H | Topical tempo |
| DE68917946T2 (de) * | 1988-01-29 | 1995-01-05 | Peter H Proctor | Haarwachstumanregung mit Nitroxyd und anderen Radikalen. |
| WO1995017900A1 (en) * | 1993-12-30 | 1995-07-06 | Arcturus Pharmaceutical Corporation | Methods for the treatment of the central nervous system or eye involving pathogenic oxidation pathways |
| ATE194596T1 (de) * | 1994-11-15 | 2000-07-15 | Moreno Paolini | N-hydroxypiperidine als superoxid-radikalfänger |
| WO1997026879A1 (en) * | 1996-01-26 | 1997-07-31 | The United States Of America, Represented By The Secretary, Department Of Health And Human Services, The National Institutes Of Health | Hydroxylamine compositions for the prevention or retardation of cataracts |
| ATE428470T1 (de) * | 2000-06-29 | 2009-05-15 | Mei Co Ltd | Heilmittel zur behandlung von erkrankungen des sehnervs |
| IT1320080B1 (it) * | 2000-10-25 | 2003-11-18 | Giuliani Spa | Composizione per uso farmaceutico o dietetico. |
| EP1507826A4 (en) * | 2002-05-17 | 2007-11-07 | Othera Pharmaceuticals Inc | IMPROVING THE EVOLUTION OF CATARACTS AND OTHER OPHTHALMIC DISEASES |
-
2004
- 2004-11-22 AU AU2004296738A patent/AU2004296738A1/en not_active Abandoned
- 2004-11-22 CN CNA2004800343580A patent/CN101102770A/zh active Pending
- 2004-11-22 KR KR1020067012250A patent/KR20070040326A/ko not_active Withdrawn
- 2004-11-22 WO PCT/US2004/039716 patent/WO2005055926A2/en not_active Ceased
- 2004-11-22 EP EP04812275A patent/EP1689354A4/en not_active Withdrawn
- 2004-11-22 CA CA002546053A patent/CA2546053A1/en not_active Abandoned
- 2004-11-22 JP JP2006541459A patent/JP2007527417A/ja active Pending
-
2006
- 2006-05-09 IL IL175498A patent/IL175498A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Casson | Medical therapy for glaucoma: A review | |
| JP2007527417A5 (https=) | ||
| RU2470635C2 (ru) | Профилактическое или терапевтическое средство, применяемое при заболеваниях заднего отдела глаза | |
| JP2008531714A (ja) | 不安障害の治療用及び／又は予防用の医薬組成物 | |
| JP2011510014A5 (https=) | ||
| JP2006524185A5 (https=) | ||
| JP6014033B2 (ja) | 防腐剤無添加ビマトプロストおよびチモロール溶液 | |
| WO2011053792A4 (en) | Methods and compositions for sustained delivery of drugs | |
| JP2008538741A (ja) | 鬱病の治療用及び／又は予防用の医薬組成物 | |
| ES2540151B1 (es) | Composición farmacéutica de ibuprofeno y tramadol para uso oftálmico | |
| RU2014123472A (ru) | Производные 4-прегенен-11ss-17-21-триол-3,20-диона для лечения глазных болезней | |
| JP2003527422A5 (https=) | ||
| JP2005527605A5 (https=) | ||
| JP2021506971A (ja) | イソキサゾリン系寄生虫駆除剤及び眼瞼炎を治療する方法 | |
| JP2010502564A5 (https=) | ||
| BRPI1016257B1 (pt) | composições compreendendo finafloxacina para tratamento de infecções óticas | |
| RU2431502C2 (ru) | Фармацевтические композиции для лечения сухости глаз | |
| CN115768419A (zh) | 用于色满卡林前药治疗的改进方法和组合物 | |
| AU2017261303A1 (en) | Ophthalmic compositions | |
| JP2024041947A (ja) | 眼圧下降増強剤 | |
| FI2765988T3 (fi) | Silmäkoostumus, joka sisältää bromfenaakkia, jolla on parannettu biologinen hyötyosuus | |
| JP2009538827A (ja) | カンナビノイドおよび使用方法 | |
| JP6116714B2 (ja) | 眼科炎症疾患治療用点眼剤組成物及びその製造方法 | |
| RU2020119228A (ru) | Соединения, композиции и способы лечения нарушений со стороны органа зрения и заболеваний кожи | |
| RU2017111579A (ru) | Способы лечения и предотвращения заболеваний глаз, расстройств и патологических состояний меланином и аналогами, предшественниками и производными меланина |